MYRIAD GENETICS, INC. Depreciation
MYRIAD GENETICS, INC. (MYGN) reported Depreciation of $4.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-07-31
- MYRIAD GENETICS, INC. depreciation for the quarter ending 2026-06-30 was $4.80M, a 2.04% decline year-over-year.
- MYRIAD GENETICS, INC. depreciation for the quarter ending 2026-03-31 was $4.70M, a 7.84% decline year-over-year.
- MYRIAD GENETICS, INC. depreciation for the quarter ending 2025-12-31 was $4.70M, a 6.00% decline year-over-year.
- MYRIAD GENETICS, INC. depreciation for the quarter ending 2025-09-30 was $4.80M, a 0.00% change year-over-year.
- MYRIAD GENETICS, INC. depreciation for fiscal 2025 was $19.50M, a 0.00% change from fiscal 2024.
- MYRIAD GENETICS, INC. depreciation for fiscal 2024 was $19.50M, a 2.09% increase from fiscal 2023.
- MYRIAD GENETICS, INC. depreciation for fiscal 2023 was $19.10M, a 64.66% increase from fiscal 2022.
- MYRIAD GENETICS, INC. depreciation for fiscal 2022 was $11.60M, a 4.13% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $4.80M 10-Q · filed 2026-07-31 | $9.50M 10-Q · filed 2026-07-31 | $14.20M derived: sum of 3 quarters · filed 2026-07-31 | $19.00M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2026-03-31 | $4.70M 10-Q · filed 2026-05-06 | $9.40M derived: sum of 2 quarters · filed 2026-05-06 | $14.20M derived: sum of 3 quarters · filed 2026-05-06 | $19.10M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2025-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $9.50M derived: sum of 2 quarters · filed 2026-02-24 | $14.40M derived: sum of 3 quarters · filed 2026-07-31 | $19.50M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $4.80M 10-Q · filed 2025-11-04 | $9.70M derived: sum of 2 quarters · filed 2026-07-31 | $14.80M 10-Q · filed 2025-11-04 | $19.80M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2025-06-30 | $4.90M 10-Q · filed 2026-07-31 | $10.00M 10-Q · filed 2026-07-31 | $15.00M derived: sum of 3 quarters · filed 2026-07-31 | $19.80M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2025-03-31 | $5.10M 10-Q · filed 2026-05-06 | $10.10M derived: sum of 2 quarters · filed 2026-05-06 | $14.90M derived: sum of 3 quarters · filed 2026-05-06 | $19.50M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $9.80M derived: sum of 2 quarters · filed 2026-02-24 | $14.40M derived: sum of 3 quarters · filed 2026-02-24 | $19.50M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $4.80M 10-Q · filed 2025-11-04 | $9.40M derived: sum of 2 quarters · filed 2025-11-04 | $14.50M 10-Q · filed 2025-11-04 | $18.60M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | $4.60M 10-Q · filed 2025-08-06 | $9.70M 10-Q · filed 2025-08-06 | $13.80M derived: sum of 3 quarters · filed 2026-02-24 | $17.20M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | $4.90M 10-Q · filed 2025-05-07 | $9.20M derived: sum of 2 quarters · filed 2026-02-24 | $12.60M derived: sum of 3 quarters · filed 2026-02-24 | $15.30M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2023-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $7.70M derived: sum of 2 quarters · filed 2026-02-24 | $10.40M derived: sum of 3 quarters · filed 2026-02-24 | $19.10M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $3.40M 10-Q · filed 2024-11-08 | $6.10M derived: sum of 2 quarters · filed 2024-11-08 | $14.80M 10-Q · filed 2024-11-08 | $17.90M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | $2.70M 10-Q · filed 2024-08-07 | $11.40M 10-Q · filed 2024-08-07 | $14.50M derived: sum of 3 quarters · filed 2025-02-28 | $17.40M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | $8.70M 10-Q · filed 2024-05-08 | $11.80M derived: sum of 2 quarters · filed 2025-02-28 | $14.70M derived: sum of 3 quarters · filed 2025-02-28 | $17.50M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $6.00M derived: sum of 2 quarters · filed 2025-02-28 | $8.80M derived: sum of 3 quarters · filed 2025-02-28 | $11.60M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $2.90M 10-Q · filed 2023-11-07 | $5.70M derived: sum of 2 quarters · filed 2023-11-07 | $8.50M 10-Q · filed 2023-11-07 | $11.70M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $2.80M 10-Q · filed 2023-08-04 | $5.60M 10-Q · filed 2023-08-04 | $8.80M derived: sum of 3 quarters · filed 2024-02-28 | $11.40M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $2.80M 10-Q · filed 2023-05-04 | $6.00M derived: sum of 2 quarters · filed 2024-02-28 | $8.60M derived: sum of 3 quarters · filed 2024-02-28 | $12.00M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $5.80M derived: sum of 2 quarters · filed 2024-02-28 | $9.20M derived: sum of 3 quarters · filed 2024-02-28 | $12.10M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $2.60M 10-Q · filed 2022-11-02 | $6.00M derived: sum of 2 quarters · filed 2022-11-02 | $8.90M 10-Q · filed 2022-11-02 | $11.50M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | $3.40M 10-Q · filed 2022-08-05 | $6.30M 10-Q · filed 2022-08-05 | $8.90M derived: sum of 3 quarters · filed 2023-03-01 | $11.30M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $2.90M 10-Q · filed 2022-05-06 | $5.50M derived: sum of 2 quarters · filed 2023-03-01 | $7.90M derived: sum of 3 quarters · filed 2023-03-01 | $10.40M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | $2.60M derived: 10-K 6 month − 10-Q 3 month · filed 2023-03-01 | $5.00M 10-K · filed 2023-03-01 | $7.50M derived: sum of 3 quarters · filed 2023-03-01 | $10.10M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-09-30 | $2.40M 10-Q · filed 2021-11-04 | $4.90M derived: sum of 2 quarters · filed 2021-11-04 | $7.50M 10-Q · filed 2021-11-04 | $10.50M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2020-06-30 | $2.50M 10-Q · filed 2021-08-04 | $5.10M 10-Q · filed 2021-08-04 | $8.10M derived: sum of 3 quarters · filed 2021-08-04 | $11.00M 10-K · filed 2023-03-01 | |
| 2020-03-31 | $2.60M 10-Q · filed 2021-05-05 | $5.60M derived: sum of 2 quarters · filed 2021-05-05 | $8.50M 10-Q · filed 2020-05-06 | $11.60M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | $3.00M 10-Q · filed 2020-02-07 | $5.90M 10-Q · filed 2020-02-07 | $9.00M derived: sum of 3 quarters · filed 2022-02-25 | $12.10M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-09-30 | $2.90M 10-Q · filed 2020-11-09 | $6.00M derived: sum of 2 quarters · filed 2022-02-25 | $9.10M derived: sum of 3 quarters · filed 2022-02-25 | $11.70M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-06-30 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $6.20M derived: sum of 2 quarters · filed 2022-02-25 | $8.80M derived: sum of 3 quarters · filed 2022-02-25 | $13.70M 10-K · filed 2022-02-25 | |
| 2019-03-31 | $3.10M 10-Q · filed 2020-05-06 | $5.70M derived: sum of 2 quarters · filed 2020-05-06 | $10.60M 10-Q · filed 2020-05-06 | $16.40M derived: sum of 4 quarters · filed 2021-03-16 | |
| 2018-12-31 | $2.60M 10-Q · filed 2020-02-07 | $7.50M 10-Q · filed 2020-02-07 | $13.30M derived: sum of 3 quarters · filed 2021-03-16 | $16.90M derived: sum of 4 quarters · filed 2021-03-16 | |
| 2018-09-30 | $4.90M 10-Q · filed 2019-11-06 | $10.70M derived: sum of 2 quarters · filed 2021-03-16 | $14.30M derived: sum of 3 quarters · filed 2021-03-16 | $18.10M derived: sum of 4 quarters · filed 2021-03-16 | |
| 2018-06-30 | $5.80M derived: 10-KT 12 month − 10-Q 9 month · filed 2021-03-16 | $9.40M derived: sum of 2 quarters · filed 2021-03-16 | $13.20M derived: sum of 3 quarters · filed 2021-03-16 | $17.10M 10-KT · filed 2021-03-16 | |
| 2018-03-31 | $3.60M 10-Q · filed 2019-05-08 | $7.40M derived: sum of 2 quarters · filed 2019-05-08 | $11.30M 10-Q · filed 2019-05-08 | $15.30M derived: sum of 4 quarters · filed 2019-08-13 | |
| 2017-12-31 | $3.80M 10-Q · filed 2019-02-06 | $7.70M 10-Q · filed 2019-02-06 | $11.70M derived: sum of 3 quarters · filed 2019-08-13 | $15.40M derived: sum of 4 quarters · filed 2019-08-13 | |
| 2017-09-30 | $3.90M 10-Q · filed 2018-11-07 | $7.90M derived: sum of 2 quarters · filed 2019-08-13 | $11.60M derived: sum of 3 quarters · filed 2019-08-13 | $15.20M derived: sum of 4 quarters · filed 2019-08-13 | |
| 2017-06-30 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-13 | $7.70M derived: sum of 2 quarters · filed 2019-08-13 | $11.30M derived: sum of 3 quarters · filed 2019-08-13 | $15.00M 10-K · filed 2019-08-13 | |
| 2017-03-31 | $3.70M 10-Q · filed 2018-05-09 | $7.30M derived: sum of 2 quarters · filed 2018-05-09 | $11.00M 10-Q · filed 2018-05-09 | $14.50M derived: sum of 4 quarters · filed 2018-08-24 | |
| 2016-12-31 | $3.60M 10-Q · filed 2018-02-07 | $7.30M 10-Q · filed 2018-02-07 | $10.80M derived: sum of 3 quarters · filed 2018-08-24 | $14.30M derived: sum of 4 quarters · filed 2018-08-24 | |
| 2016-09-30 | $3.70M 10-Q · filed 2017-11-08 | $7.20M derived: sum of 2 quarters · filed 2018-08-24 | $10.70M derived: sum of 3 quarters · filed 2018-08-24 | $14.30M derived: sum of 4 quarters · filed 2018-08-24 | |
| 2016-06-30 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-24 | $7.00M derived: sum of 2 quarters · filed 2018-08-24 | $10.60M derived: sum of 3 quarters · filed 2018-08-24 | $14.10M 10-K · filed 2018-08-24 | |
| 2016-03-31 | $3.50M 10-Q · filed 2017-05-03 | $7.10M derived: sum of 2 quarters · filed 2017-05-03 | $10.60M 10-Q · filed 2017-05-03 | $14.20M derived: sum of 4 quarters · filed 2017-08-09 | |
| 2015-12-31 | $3.60M 10-Q · filed 2017-02-08 | $7.20M 10-Q · filed 2017-02-08 | $10.70M derived: sum of 3 quarters · filed 2017-08-09 | $14.00M derived: sum of 4 quarters · filed 2017-08-09 | |
| 2015-09-30 | $3.60M 10-Q · filed 2016-11-02 | $7.10M derived: sum of 2 quarters · filed 2017-08-09 | $10.40M derived: sum of 3 quarters · filed 2017-08-09 | $13.30M derived: sum of 4 quarters · filed 2017-08-09 | |
| 2015-06-30 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-09 | $6.80M derived: sum of 2 quarters · filed 2017-08-09 | $9.70M derived: sum of 3 quarters · filed 2017-08-09 | $12.30M 10-K · filed 2017-08-09 | |
| 2015-03-31 | $3.30M 10-Q · filed 2016-05-04 | $6.20M derived: sum of 2 quarters · filed 2016-05-04 | $8.80M 10-Q · filed 2016-05-04 | ||
| 2014-12-31 | $2.90M 10-Q · filed 2016-02-03 | $5.50M 10-Q · filed 2016-02-03 | |||
| 2014-09-30 | $2.60M 10-Q · filed 2015-11-04 | ||||
| 2014-06-30 | $9.20M 10-K · filed 2016-08-10 | $9.19M 10-K · filed 2014-08-13 | |||
| 2013-06-30 | $8.00M 10-K · filed 2015-08-12 | $7.99M 10-K · filed 2013-08-14 | |||
| 2012-06-30 | $7.97M 10-K · filed 2014-08-13 | ||||
| 2011-06-30 | $6.83M 10-K · filed 2013-08-14 | ||||
| 2010-06-30 | $6.76M 10-K · filed 2012-08-15 | ||||
| 2009-06-30 | $9.03M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |